Bio-Rad Laboratories (NYSE: BIO.B)
Bio-Rad Laboratories Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bio-Rad Laboratories Company Info
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Valuation
Earnings Transcripts
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript
BIO, BIO.B earnings call for the period ending June 30, 2020.
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q1 2020 Earnings Call Transcript
BIO, BIO.B earnings call for the period ending March 31, 2020.
Bio-Rad Laboratories Inc (BIO) (BIO-B) Q3 2019 Earnings Call Transcript
BIO, BIO-B earnings call for the period ending September 30, 2019.
Bio-Rad Laboratories Inc (BIO) (BIO-B) Q2 2019 Earnings Call Transcript
BIO, BIO-B earnings call for the period ending June 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.